Who is sponsoring NCT00240344?

NCT00240344 is sponsored by AstraZeneca.

What condition does NCT00240344 study?

NCT00240344 studies Hypercholesterolemia.

What is the status of NCT00240344?

NCT00240344 is currently COMPLETED.

Last reviewed 2011-08-29 · How we verify

REALISTIC: Protocol for an Observational Study in High Risk Patients Switched From Higher Doses of Other Statins to Crestor on the Percentage of Patients Reaching the New EAS LDL-C Target Goal

NCT00240344 COMPLETED

The purpose of this study is to determine the efficacy of Crestor in high risk patients switched from higher doses of other statins in obtaining the new European Atherosclerosis Society (EAS) low-density lipoprotein cholesterol (LDL-C) guidelines.

Details

Lead sponsor	AstraZeneca
Status	COMPLETED
Enrolment	2650
Start date	2004-09
Completion	2008-02

Conditions

Hypercholesterolemia

Countries

Netherlands